Xenetic Biosciences Gestione
Gestione criteri di controllo 3/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Jim Parslow
Amministratore delegato
US$433.7k
Compenso totale
| Percentuale dello stipendio del CEO | 75.9% |
| Mandato del CEO | 7.6yrs |
| Proprietà del CEO | n/a |
| Durata media del management | Nessun dato |
| Durata media del Consiglio di amministrazione | 5.3yrs |
Aggiornamenti recenti sulla gestione
Most Shareholders Will Probably Find That The Compensation For Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Is Reasonable
Dec 15
Why We Think Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation Is Not Excessive At All
Dec 01Recent updates
Most Shareholders Will Probably Find That The Compensation For Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Is Reasonable
Dec 15Why We Think Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation Is Not Excessive At All
Dec 01Xenetic Biosciences reports Q2 results
Aug 12Xenetic Biosciences, VolitionRx collaborate to develop cell therapies to treat cancer
Aug 02Xenetic inks clinical manufacturing contract with Catalent
Jul 07Xenetic Biosciences reports Q3 results
Nov 13Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$4m |
| Jun 30 2024 | n/a | n/a | -US$5m |
| Mar 31 2024 | n/a | n/a | -US$4m |
| Dec 31 2023 | US$434k | US$329k | -US$4m |
| Sep 30 2023 | n/a | n/a | -US$4m |
| Jun 30 2023 | n/a | n/a | -US$4m |
| Mar 31 2023 | n/a | n/a | -US$6m |
| Dec 31 2022 | US$474k | US$329k | -US$7m |
| Sep 30 2022 | n/a | n/a | -US$7m |
| Jun 30 2022 | n/a | n/a | -US$7m |
| Mar 31 2022 | n/a | n/a | -US$6m |
| Dec 31 2021 | US$521k | US$299k | -US$6m |
| Sep 30 2021 | n/a | n/a | -US$5m |
| Jun 30 2021 | n/a | n/a | -US$11m |
| Mar 31 2021 | n/a | n/a | -US$11m |
| Dec 31 2020 | US$359k | US$285k | -US$11m |
| Sep 30 2020 | n/a | n/a | -US$11m |
| Jun 30 2020 | n/a | n/a | -US$14m |
| Mar 31 2020 | n/a | n/a | -US$14m |
| Dec 31 2019 | US$388k | US$265k | -US$18m |
| Sep 30 2019 | n/a | n/a | -US$19m |
| Jun 30 2019 | n/a | n/a | -US$10m |
| Mar 31 2019 | n/a | n/a | -US$11m |
| Dec 31 2018 | US$288k | US$265k | -US$7m |
| Sep 30 2018 | n/a | n/a | -US$1m |
| Jun 30 2018 | n/a | n/a | -US$2m |
| Mar 31 2018 | n/a | n/a | -US$3m |
| Dec 31 2017 | US$960k | US$199k | -US$4m |
Compensazione vs Mercato: La retribuzione totale di Jim ($USD 433.73K ) è inferiore alla media delle aziende di dimensioni simili nel mercato US ($USD 646.00K ).
Compensazione vs guadagni: La retribuzione di Jim è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Jim Parslow (59 yo)
7.6yrs
Mandato
US$433,732
Compensazione
Mr. James F. Parslow, also known as Jim, has been Chief Financial Officer at Xenetic Biosciences, Inc. since April 03, 2017 and serves as its Chief Operating Officer and Corporate Secretary and serves as i...
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| President & Director | 8.3yrs | US$563.49k | 0.027% $ 1.7k | |
| Independent Non Executive Director | less than a year | US$12.33k | 0% $ 0 | |
| Independent Director | 8.8yrs | US$57.54k | 0% $ 0 | |
| Independent Director | 10.8yrs | US$57.54k | 0% $ 0 | |
| Non-Executive Director | less than a year | Nessun dato | 4.44% $ 276.6k | |
| Member of Scientific Advisory Board | 5.5yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | 5.8yrs | Nessun dato | Nessun dato | |
| Independent Director | 5.3yrs | US$57.54k | Nessun dato | |
| Independent Non-Executive Director | 5.2yrs | US$57.54k | 0% $ 0 | |
| Member of Scientific Advisory Board | 4.8yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | 2.5yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | 2yrs | Nessun dato | Nessun dato |
5.3yrs
Durata media
58yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di XBIO sono considerati esperti (durata media dell'incarico 5.3 anni).